Adhesion G Protein-Coupled Receptor L4 (ADGRL4) Antibody (FITC)

169€ (20 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Adhesion G Protein-Coupled Receptor L4 (ADGRL4) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx311222
Description
ADGRL4 Antibody (FITC) is a Rabbit Polyclonal against ADGRL4 conjugated to FITC.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Adhesion G Protein-Coupled Receptor L4 (ADGRL4) |
Host | Rabbit |
Reactivity | Human |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | FITC |
Isotype | IgG |
Purity | > 95% |
Purification | Purified by Protein G. |
Size 1 | 20 µg |
Size 2 | 50 µg |
Size 3 | 100 µg |
Size 4 | 200 µg |
Size 5 | 1 mg |
Form | Liquid |
Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q9HBW9 |
Gene ID | 64123 |
OMIM | 616419 |
Alias | ADGRL4,ETL,EGF-TM7-latrophilin-related protein,ELTD1 |
Background | Antibody anti-ADGRL4 |
Status | RUO |
Descripción
ADGRL4, formerly known as ELTD1 (EGF, Latrophilin, and Seven-Transmembrane Domain-Containing Protein 1), is expressed in vascular endothelial cells and plays an essential role in vascular remodeling, angiogenesis, and endothelial cell migration. By interacting with extracellular matrix components and signaling proteins, ADGRL4 influences cellular communication, proliferation, and the structural organization of blood vessels. It has been extensively studied for its involvement in tumor angiogenesis, where its overexpression correlates with aggressive cancer progression and poor prognosis. Beyond its role in pathological angiogenesis, ADGRL4 is critical for maintaining vascular stability and endothelial barrier function under normal physiological conditions. Dysregulation of ADGRL4 is associated with pathological vascular remodeling and cardiovascular diseases, emphasizing its potential as a therapeutic target in oncology and vascular medicine. Its multifunctional nature makes it a key player in both physiological vascular processes and disease states.
Related Products

EGF, Latrophilin And Seven Transmembrane Domain-Containing Protein 1 (ELTD1) Antibody
ELTD1 Antibody is a Rabbit Polyclonal against ELTD1.
Ver Producto
Adhesion G Protein-Coupled Receptor L4 (ADGRL4) Antibody
ADGRL4 Antibody is a Rabbit Polyclonal against ADGRL4.
Ver Producto
Adhesion G Protein-Coupled Receptor L4 (ADGRL4) Antibody (HRP)
ADGRL4 Antibody (HRP) is a Rabbit Polyclonal against ADGRL4 conjugated to HRP.
Ver Producto